These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 28807439)
1. Tetrahydrobenzothiophene carboxamides: Beyond the kinase domain and into the fatty acid realm. Llona-Minguez S; Fayezi S; Alihemmati A; Juárez-Jiménez J; Piedrafita FJ; Helleday T Bioorg Med Chem Lett; 2017 Sep; 27(18):4462-4466. PubMed ID: 28807439 [TBL] [Abstract][Full Text] [Related]
2. Benzimidazole-carboxamides as potent and bioavailable stearoyl-CoA desaturase (SCD1) inhibitors from ligand-based virtual screening and chemical optimization. Matter H; Zoller G; Herling AW; Sanchez-Arias JA; Philippo C; Namane C; Kohlmann M; Pfenninger A; Voss MD Bioorg Med Chem Lett; 2013 Mar; 23(6):1817-22. PubMed ID: 23395660 [TBL] [Abstract][Full Text] [Related]
3. Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors. Xin Z; Zhao H; Serby MD; Liu B; Liu M; Szczepankiewicz BG; Nelson LT; Smith HT; Suhar TS; Janis RS; Cao N; Camp HS; Collins CA; Sham HL; Surowy TK; Liu G Bioorg Med Chem Lett; 2008 Aug; 18(15):4298-302. PubMed ID: 18632269 [TBL] [Abstract][Full Text] [Related]
4. Recent progress in the discovery and development of stearoyl CoA desaturase inhibitors. Uto Y Chem Phys Lipids; 2016 May; 197():3-12. PubMed ID: 26344107 [TBL] [Abstract][Full Text] [Related]
5. Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series. Lachance N; Gareau Y; Guiral S; Huang Z; Isabel E; Leclerc JP; Léger S; Martins E; Nadeau C; Oballa RM; Ouellet SG; Powell DA; Ramtohul YK; Tranmer GK; Trinh T; Wang H; Zhang L Bioorg Med Chem Lett; 2012 Jan; 22(2):980-4. PubMed ID: 22209206 [TBL] [Abstract][Full Text] [Related]
6. Discovery of Novel and Potent Stearoyl Coenzyme A Desaturase 1 (SCD1) Inhibitors as Anticancer Agents. Imamura K; Tomita N; Kawakita Y; Ito Y; Ono K; Nii N; Miyazaki T; Yonemori K; Tawada M; Sumi H; Satoh Y; Yamamoto Y; Miyahisa I; Sasaki M; Satomi Y; Hirayama M; Nishigaki R; Maezaki H Bioorg Med Chem; 2017 Jul; 25(14):3768-3779. PubMed ID: 28571972 [TBL] [Abstract][Full Text] [Related]
7. Biosynthesis of Polyunsaturated Fatty Acids in Octopus vulgaris: Molecular Cloning and Functional Characterisation of a Stearoyl-CoA Desaturase and an Elongation of Very Long-Chain Fatty Acid 4 Protein. Monroig Ó; de Llanos R; Varó I; Hontoria F; Tocher DR; Puig S; Navarro JC Mar Drugs; 2017 Mar; 15(3):. PubMed ID: 28335553 [TBL] [Abstract][Full Text] [Related]
8. 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogs. Yang SM; Tang Y; Rano T; Lu H; Kuo GH; Gaul MD; Li Y; Ho G; Lang W; Conway JG; Liang Y; Lenhard JM; Demarest KT; Murray WV Bioorg Med Chem Lett; 2014 Mar; 24(5):1437-41. PubMed ID: 24405703 [TBL] [Abstract][Full Text] [Related]
9. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry. Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133 [TBL] [Abstract][Full Text] [Related]
10. Stearoyl-CoA desaturase 1, elongase 6 and their fatty acid products and precursors are altered in ovariectomized rats with 17β-estradiol and progesterone treatment. Marks KA; Kitson AP; Shaw B; Mutch DM; Stark KD Prostaglandins Leukot Essent Fatty Acids; 2013 Aug; 89(2-3):89-96. PubMed ID: 23777599 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of stearoyl-CoA desaturase1 activates AMPK and exhibits beneficial lipid metabolic effects in vitro. Kim E; Lee JH; Ntambi JM; Hyun CK Eur J Pharmacol; 2011 Dec; 672(1-3):38-44. PubMed ID: 21970804 [TBL] [Abstract][Full Text] [Related]
13. Stearoyl-CoA desaturase activity in adipose tissue and liver of the cardiomyopathic hamster. Barakat HA; Brown WE; Debnath S Lipids; 1978 Sep; 13(9):622-6. PubMed ID: 30875 [No Abstract] [Full Text] [Related]
14. Discovery of 1-(4-phenoxypiperidin-1-yl)-2-arylaminoethanone stearoyl-CoA desaturase 1 inhibitors. Zhao H; Serby MD; Smith HT; Cao N; Suhar TS; Surowy TK; Camp HS; Collins CA; Sham HL; Liu G Bioorg Med Chem Lett; 2007 Jun; 17(12):3388-91. PubMed ID: 17434733 [TBL] [Abstract][Full Text] [Related]
15. Stearoyl-CoA desaturase as a new drug target for obesity treatment. Dobrzyn A; Ntambi JM Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467 [TBL] [Abstract][Full Text] [Related]
16. 4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: urea-based analogs. Yang SM; Tang Y; Zhang R; Lu H; Kuo GH; Gaul MD; Li Y; Ho G; Conway JG; Liang Y; Lenhard JM; Demarest KT; Murray WV Bioorg Med Chem Lett; 2013 Dec; 23(24):6773-6. PubMed ID: 24153205 [TBL] [Abstract][Full Text] [Related]
17. Development of a novel LC/MS method to quantitate cellular stearoyl-CoA desaturase activity. Dillon R; Greig MJ; Bhat BG Anal Chim Acta; 2008 Oct; 627(1):99-104. PubMed ID: 18790132 [TBL] [Abstract][Full Text] [Related]